查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485750

RNA 干扰技术市场，按类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

RNA Interference Technology Market, By Type, By Application, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年RNA干扰技术市场规模为15.4562亿美元，2024年至2032年复合年增长率为16.5%。

RNA干扰技术市场-市场动态

RNA 干扰技术在推进精准医学中的作用

RNA 干扰 (RNAi) 技术透过提供个人化治疗方案，在推进精准医疗方面发挥关键作用。例如，美国国立卫生研究院 (NIH) 的研究人员利用 RNAi 来靶向与癌症相关的特定基因，在肿瘤抑制和个人化治疗方法方面展示了有希望的结果。此外，Alnylam Pharmaceuticals 等製药公司也开发了基于 RNAi 的罕见遗传性疾病疗法，体现了 RNAi 在满足个别患者需求方面的变革潜力。该技术能够根据患者特定的基因谱进行精确的基因沉默，促进提高疗效并减少副作用的标靶治疗的开发，从而彻底改变个人化医疗的格局。

RNA干扰技术市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 16.5% 左右的复合年增长率成长

根据类型细分，预计 siRNA 将在 2023 年显示最大的市场份额

从应用细分来看，治疗类是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

RNA干扰技术市场-細項分析：

全球 RNA 干扰技术市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为三类：dsRNA、siRNA 和 miRNA。短干扰RNA (siRNA) 由于其在基因沉默方面的特异性和有效性而拥有最高的偏好，其次是微小RNA (miRNA)，因其在基因表现中的调节作用而闻名。由于脱靶效应和先天免疫反应，双股 RNA (dsRNA) 较不受欢迎。

市场根据应用分为三类：药物发现和开发、治疗和农作物改良。由于精准医学和个人化治疗中对基于 RNAi 的治疗的需求不断增长，治疗学排名最高。药物发现和开发紧随其后，利用 RNAi 技术进行标靶验证和药物筛选。由于监管挑战和市场复杂性，农作物改良和其他应用的偏好较低。

RNA干扰技术市场-地理洞察

北美，特别是美国，在 Alnylam Pharmaceuticals 和 Arrowhead Pharmaceuticals 等主要参与者的支持下，在生物技术和製药领域开展了强劲的研发活动，从而引领市场。在欧洲，德国、英国和瑞士等国家在学术与产业合作的支持下，透过强大的生物医学研究和临床应用来推动采用。在中国、日本和印度等国家不断增加的医疗支出、生物技术研究投资以及政府对基因组医学的支持的推动下，亚太地区呈现快速成长。拉丁美洲提供了对精准医学和基因疗法的关注而带来的机会，改善的医疗基础设施和监管发展有助于市场扩张。在医疗基础设施投资和个人化医疗意识不断提高的支持下，中东和非洲也出现了成长，合作加强了该地区的技术转移和市场发展。

RNA干扰技术市场-竞争格局：

Alnylam Pharmaceuticals、Arrowhead Pharmaceuticals、Dicerna Pharmaceuticals、Quark Pharmaceuticals 和 Silence Therapeutics 等几家主要参与者都在推动基于 RNAi 的疗法的创新和产品开发。 Alnylam Pharmaceuticals 因其专注于罕见遗传疾病而脱颖而出，而 Arrowhead Pharmaceuticals 则专注于基于 RNAi 的肝病和癌症药物。着名的合作实例包括 Alnylam Pharmaceuticals 与 Regeneron Pharmaceuticals 合作，利用 Alnylam 在 RNAi 治疗方面的专业知识和 Regeneron 在抗体技术方面的能力，开发基于 RNAi 的眼部和中枢神经系统疾病治疗方法。 Dicerna Pharmaceuticals 利用其专有的 RNAi 技术平台来治疗各种疾病途径，而 Quark Pharmaceuticals 则专注于眼部疾病和肾臟损伤。 Silence Therapeutics 利用先进的递送系统开发针对心血管疾病、癌症和罕见遗传性疾病的 RNAi 疗法。这些公司在技术进步、治疗管道以及与学术和製药合作伙伴的策略合作方面展开竞争，反映了动态的市场格局，正在进行的研究和临床试验旨在证明基于 RNAi 的疗法的有效性和安全性。

最近的发展：

2024 年 4 月，Medison Pharma 和 Alnylam Pharmaceuticals, Inc. 宣布进一步扩大其在中欧、东欧和以色列的现有合作伙伴关係，以在包括澳洲在内的其他拉丁美洲和亚太市场将 RNAi 疗法商业化。

2023 年 6 月，加拿大害虫管理研究机构批准了一项 RNAi 生物农药输送技术的实地研究，这是一种保护农作物免受昆虫侵害的环保方式。

目录

第 1 章：RNA 干扰技术市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的 RNA 干扰技术市场片段
    • RNA 干扰技术市场片段（依应用）
    • 最终用户的 RNA 干扰技术市场片段
    • 按国家/地区分類的 RNA 干扰技术市场片段
    • 按地区分類的 RNA 干扰技术市场片段
  • 竞争洞察

第 3 章：RNA 干扰技术主要市场趋势

  • RNA干扰技术市场驱动因素
    • 市场驱动因素的影响分析
  • RNA干扰技术市场限制
    • 市场限制影响分析
  • RNA干扰技术的市场机会
  • RNA干扰技术市场未来趋势

第 4 章：RNA 干扰技术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：RNA 干扰技术市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：RNA 干扰技术市场模式

  • 2023 年 RNA 干扰技术市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：RNA 干扰技术市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 双股RNA
    • siRNA
    • miRNA

第 8 章：RNA 干扰技术市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 药物发现与开发
    • 疗法
    • 农作物改良
    • 其他的

第 9 章：RNA 干扰技术市场 - 由最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 生技公司
    • 合约研究组织
    • 学术界
    • 研究中心
    • 其他的

第 10 章：RNA 干扰技术市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • RNA干扰技术北美主要厂商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲RNA干扰技术主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太区RNA干扰技术主要厂商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区最终用户市场规模与预测
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲RNA干扰技术主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲RNA干扰技术主要生产商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第11章：RNA干扰技术产业主要供应商分析

  • 竞争仪表板
  • 公司简介
    • Alnylam Pharmaceuticals, Inc.
    • Arbutus Biopharma Corporation
    • Arrowhead Pharmaceuticals, Inc.
    • Benitec Biopharma Limited
    • DicereGen, Inc.
    • Dicerna Pharmaceuticals, Inc.
    • Gradalis, Inc.
    • Ionis Pharmaceuticals, Inc.
    • miRagen Therapeutics, Inc.
    • Quark Pharmaceuticals, Inc.
    • Regulus Therapeutics Inc.
    • RXi Pharmaceuticals Corporation
    • Silence Therapeutics plc
    • Sirnaomics, Inc.
    • Sylentis SAU (PharmaMar Group)
    • Tacere Therapeutics, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2648

REPORT HIGHLIGHT

RNA Interference Technology Market size was valued at USD 1,545.62 Million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032.

The RNA interference (RNAi) technology market involves using small RNA molecules to silence gene expression, with applications in gene therapy, drug discovery, and functional genomics. Increasing demand for precise therapies in personalized medicine, and advancements in drug delivery systems enabling efficient RNAi-based treatments are driving the demand for the market. However, challenges such as off-target effects, and delivery complexities impede market growth. Opportunities exist in applying RNAi to neurodegenerative diseases, forming partnerships for innovative therapies and delivery methods, and entering untapped markets in developing regions with rising healthcare investment and research activity, promising prospects for RNAi technology adoption.

RNA Interference Technology Market- Market Dynamics

RNA Interference Technology's Role in Advancing Precision Medicine

RNA interference (RNAi) technology is pivotal in advancing precision medicine by offering personalized treatment options. For instance, researchers at the National Institutes of Health (NIH) have utilized RNAi to target specific genes implicated in cancer, demonstrating promising results in tumor suppression and personalized therapy approaches. Additionally, pharmaceutical companies like Alnylam Pharmaceuticals have developed RNAi-based therapeutics for rare genetic disorders, exemplifying the transformative potential of RNAi in addressing individual patient needs. This technology enables precise gene silencing tailored to patient-specific genetic profiles, facilitating the development of targeted therapies with enhanced efficacy and reduced side effects, thereby revolutionizing the landscape of personalized medicine.

RNA Interference Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)

Based on Type segmentation, siRNA was predicted to show maximum market share in the year 2023

Based on application segmentation, therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

RNA Interference Technology Market- Segmentation Analysis:

The Global RNA Interference Technology Market is segmented based on Type, Application, End-Users, and Region.

The market is divided into three categories based on Type: dsRNA, siRNA, and miRNA. Short interfering RNA (siRNA) holds the highest preference due to its specificity and effectiveness in gene silencing, followed by microRNA (miRNA), known for its regulatory role in gene expression. Double-stranded RNA (dsRNA) is less favored due to off-target effects and innate immune responses.

The market is divided into three categories based on application: Drug Discovery and Development, Therapeutics, and Agricultural Crop Modifications. Therapeutics ranks highest, driven by increasing demand for RNAi-based treatments in precision medicine and personalized therapies. Drug discovery and development follow closely, leveraging RNAi technology for target validation and drug screening. Agricultural crop modifications and other applications exhibit lower preference due to regulatory challenges and market complexity.

RNA Interference Technology Market- Geographical Insights

North America, particularly the United States, leads the market with robust research and development activities in the biotechnology and pharmaceutical sectors, supported by key players like Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals. In Europe, countries such as Germany, the UK, and Switzerland drive adoption through strong biomedical research and clinical applications, bolstered by academic-industry collaborations. The Asia Pacific region shows rapid growth, driven by increasing healthcare expenditure, biotechnology research investments, and governmental support for genomic medicine in countries like China, Japan, and India. Latin America presents opportunities fueled by the focus on precision medicine and genetic therapies, with improving healthcare infrastructure and regulatory developments aiding market expansion. The Middle East and Africa also see growth, supported by healthcare infrastructure investments and rising awareness about personalized medicine, with collaborations enhancing technology transfer and market development in the region.

RNA Interference Technology Market- Competitive Landscape:

Several key players such as Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Quark Pharmaceuticals, and Silence Therapeutics, all drive innovation and product development in RNAi-based therapeutics. Alnylam Pharmaceuticals stands out for its focus on rare genetic diseases, while Arrowhead Pharmaceuticals specializes in RNAi-based drugs for liver diseases and cancer. Notable instances of collaboration include Alnylam Pharmaceuticals' partnership with Regeneron Pharmaceuticals to develop RNAi-based treatments for ocular and CNS diseases, leveraging Alnylam's expertise in RNAi therapeutics and Regeneron's capabilities in antibody technologies. Dicerna Pharmaceuticals leverages its proprietary RNAi technology platform for various disease pathways, and Quark Pharmaceuticals focuses on ocular diseases and kidney injuries. Silence Therapeutics develops RNAi therapies for cardiovascular diseases, cancer, and rare genetic disorders using advanced delivery systems. These companies compete on technological advancements, therapeutic pipelines, and strategic collaborations with academic and pharmaceutical partners, reflecting a dynamic market landscape with ongoing research and clinical trials to demonstrate the efficacy and safety of RNAi-based therapies.

Recent Developments:

In April 2024, Medison Pharma and Alnylam Pharmaceuticals, Inc. announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia.

In June 2023, Canada's Pest Management Research Agency approved a field study for RNAi biopesticide delivery technology, which is an eco-friendly way to protect crops from insects.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alnylam Pharmaceuticals, Inc.

Arbutus Biopharma Corporation

Arrowhead Pharmaceuticals, Inc.

Benitec Biopharma Limited

DicereGen, Inc.

Dicerna Pharmaceuticals, Inc.

Gradalis, Inc.

Ionis Pharmaceuticals, Inc.

miRagen Therapeutics, Inc.

Quark Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

RXi Pharmaceuticals Corporation

Silence Therapeutics plc

Sirnaomics, Inc.

Sylentis S.A.U. (PharmaMar Group)

Tacere Therapeutics, Inc.

Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • dsRNA
  • siRNA
  • miRNA

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery and Development
  • Therapeutics
  • Agricultural Crop Modifications
  • Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Academia
  • Research Centers
  • Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.RNA Interference Technology Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.RNA Interference Technology Market Snippet by Type
    • 2.1.2.RNA Interference Technology Market Snippet by Application
    • 2.1.3.RNA Interference Technology Market Snippet by End-Users
    • 2.1.4.RNA Interference Technology Market Snippet by Country
    • 2.1.5.RNA Interference Technology Market Snippet by Region
  • 2.2.Competitive Insights

3.RNA Interference Technology Key Market Trends

  • 3.1.RNA Interference Technology Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.RNA Interference Technology Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.RNA Interference Technology Market Opportunities
  • 3.4.RNA Interference Technology Market Future Trends

4.RNA Interference Technology Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.RNA Interference Technology Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.RNA Interference Technology Market Landscape

  • 6.1.RNA Interference Technology Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.RNA Interference Technology Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.dsRNA
    • 7.1.3.siRNA
    • 7.1.4.miRNA

8.RNA Interference Technology Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Discovery and Development
    • 8.1.3.Therapeutics
    • 8.1.4.Agricultural Crop Modifications
    • 8.1.5.Others

9.RNA Interference Technology Market - By End-Users

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Users, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical Companies
    • 9.1.3.Biotechnology Companies
    • 9.1.4.Contract Research Organizations
    • 9.1.5.Academia
    • 9.1.6.Research Centers
    • 9.1.7.Others

10.RNA Interference Technology Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.RNA Interference Technology Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.RNA Interference Technology Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.RNA Interference Technology Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.RNA Interference Technology Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.RNA Interference Technology Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- RNA Interference Technology Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Alnylam Pharmaceuticals, Inc.
    • 11.2.2.Arbutus Biopharma Corporation
    • 11.2.3.Arrowhead Pharmaceuticals, Inc.
    • 11.2.4.Benitec Biopharma Limited
    • 11.2.5.DicereGen, Inc.
    • 11.2.6.Dicerna Pharmaceuticals, Inc.
    • 11.2.7.Gradalis, Inc.
    • 11.2.8.Ionis Pharmaceuticals, Inc.
    • 11.2.9.miRagen Therapeutics, Inc.
    • 11.2.10.Quark Pharmaceuticals, Inc.
    • 11.2.11.Regulus Therapeutics Inc.
    • 11.2.12.RXi Pharmaceuticals Corporation
    • 11.2.13.Silence Therapeutics plc
    • 11.2.14.Sirnaomics, Inc.
    • 11.2.15.Sylentis S.A.U. (PharmaMar Group)
    • 11.2.16.Tacere Therapeutics, Inc.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Interference Technology Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global RNA Interference Technology Market, by Type 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global RNA Interference Technology Market, by Application 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: End-Users Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global RNA Interference Technology Market, by End-Users 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Interference Technology Market, by Region 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)